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Genomic imprinting is an epigenetic process responsible for the monoallelic 9 
expression of a subset of genes in mammals. Imprinted genes have been 10 
demonstrated to play important functions prenatally regulating fetal growth and 11 
placental development with some functions persisting beyond pregnancy to 12 
influence both metabolism and behaviour in adults. This review focuses on the 13 
function of imprinted genes in regulating placental hormones, and the probability 14 
that these functions manifest their impact beyond pregnancy. 15 
 16 
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Central to the reproductive success of mammals is the in utero provision of nutrients to 18 
their young via specialised extraembryonic lineages [1]. All extant mammals (monotremes, 19 
marsupials and eutherians) rely initially on a yolk sac placenta with some marsupials and 20 
all eutherians mammals switching to a more substantial chorioallantoic placenta as 21 
gestation proceeds. The mammalian mother continues providing nutrients to their young 22 
after birth in the form of milk secretions from mammary patches (monotremes) or more 23 
complex mammary glands. High quality maternal care is another vitally important factor in 24 
newborn survival with mothers providing body warmth, protection against the environment 25 
and potentially fending off predators at risk to her personal safety. The provision of 26 
nutrients and care is not simply a passive process but requires substantial physiological 27 
and behavioural changes in the mother most of which take place during pregnancy and 28 
some of which only become apparent after birth. The provision of resources primarily or 29 
exclusively by the mother in mammals suggests a conflict between the mother’s genes 30 
and the father’s genes [2, 3]. Simply, it would be advantageous for the paternal genome to 31 
extract nourishment from the mother as there is not cost but the maternal genome must 32 
ensure a more equitably allocation of maternal resources across numerous pregnancies. 33 
Imprinted genes, expressed from a single parental allele as a consequence of germline 34 
epigenetic events [4], are thought to be the physical embodiment of this conflict. In support 35 
of this hypothesis, the number of genes subject to genomic imprinting correlates well with 36 
the progressive trend toward internal development and viviparity in mammals with 37 
marsupials possessing fewer imprinted genes than the well studied Eutherian mammals, 38 
represented by mice and humans [5, 6]. Moreover, numerous studies in genetically altered 39 
mice have identified imprinted genes that influence fetal weight, placental development, 40 
maternal behaviour, lactation and thermogenesis [7-9] in a manner generally consistent 41 
with the conflict theory.  42 
 43 
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A major function of imprinted genes in the placenta is the regulation of nutrient transport 44 
primarily inferred from studies on the paternally expressed/maternally silenced insulin-like 45 
growth receptor 2 gene, and extensively reviewed [10]. Nutrient transport is determined by 46 
the demand requirements of the fetus and placenta, which both place a substantial burden 47 
on maternal resources during pregnancy. The mammalian mother also exclusively 48 
supplies nutrients, in the form of milk, after birth. The supply of nutrients prenatally and in 49 
the immediate postnatal period requires significant adaptations to maternal physiology, 50 
which must be carefully balanced for a successful pregnancy. Effectively, the mother must 51 
be able to supply all the nutritional requirements of her developing young while 52 
maintaining her own health and welfare. To achieve nutrient supply in pregnancy, maternal 53 
food intake increases, peripheral insulin resistance increases and there is an up-regulation 54 
of maternal pancreatic islet function alongside a lowered threshold for glucose stimulated 55 
insulin all of which channel maternal nutrients to the fetus [11]. During pregnancy maternal 56 
fat depots are also laid down, and changes take place in the mammary gland in 57 
preparation for the supply of milk in the postnatal period. Placental hormones are key to 58 
the induction and maintenance of these changes in maternal physiology during pregnancy 59 
[12].  60 
 61 
Perhaps the most well studied placental hormones belong to the somatotropin/prolactin 62 
family. These belong to a complex family of hormones related to prolactin (expressed in 63 
the pituitary) that originated from a common ancestral gene. This same ancestral gene 64 
also gave rise to pituitary expressed growth hormone and, in some mammalian species, 65 
further duplication to produce placental-specific growth hormone. Together, all these 66 
hormones could be viewed as one gene family encompassing both prolactin- and growth 67 
hormone-like activities, distinguished by their interaction with their cognate receptors, the 68 
growth hormones receptor and the prolactin receptor [13]. In mice, there are 22 prolactin 69 
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family members expressed almost exclusively in the placenta and no equivalent for 70 
placental growth hormone gene [14]. However, only a small subset of these hormones 71 
possess the capacity to activate the prolactin receptor [15]. In humans there are two 72 
functional prolactin family members expressed in the placenta (chorionic 73 
somatomammotropin hormone 1 and 2) encoding placental lactogen, and one placental 74 
growth hormone gene [16]. One of the key changes in pregnancy thought to be induced by 75 
a growth hormone-like activity is the increase maternal insulin resistance required to 76 
channel maternal glucose to the fetus [17]. Glucose is transported via a passive process 77 
that requires a higher concentration in the maternal circulation than in the fetus. Insulin 78 
resistance contributes to this gradient but must be balanced by the ability to respond 79 
rapidly to meals in order to avoid dangerously high levels of blood glucose. This balance is 80 
achieved, in part, through the prolactin-like function of this gene family up-regulating 81 
maternal islet function and accommodating the increased demand for insulin during 82 
pregnancy [18, 19]. Placental lactogens also play an important role in preparing the new 83 
mother to provide nutrients after birth by priming the mammary gland for lactation [20]. 84 
Placental lactogens may additionally be involved in the induction of maternal care. Both 85 
pituitary prolactin and placental lactogen have been shown to stimulate maternal care in 86 
non-pregnant rodents likely influencing maternal care through their interaction with the 87 
maternal prolactin receptor, most clearly demonstrated in rodents [21].  88 
 89 
In mice and humans, placental lactogens are expressed by derivatives of the trophoblast 90 
lineage, a specialised cell type that emerges from the first differentiation event in 91 
development [22]. Early in pregnancy, trophoblast cells contribute to the choriovitelline 92 
(yolk sac) placenta, a structure that is replaced as gestation proceeds by the 93 
chorioallantoic (mature) placenta. In mice, there are four main region of the chorioallantoic 94 
placenta: the maternally-derived decidua, a single layer of cells with giant nuclei called the 95 
 5 
secondary parietal trophoblast giant cells (TGCs), the junctional zone and the labyrinth 96 
[23]. The junctional zone contains two distinct lineages, the spongiotrophoblast and the 97 
glycogen cells, while the bulk of the labyrinth is composed of fetal endothelium surrounded 98 
by a trilaminar layer of trophoblast-derived cells consisting of a single mononuclear TGC 99 
layer (sinusoidal; previously called trophoblast layer I) and two multinucleated 100 
syncytiotrophoblast layers that function in nutrient transport (I and II; previously called 101 
layers II and II). Three other distinct TGC placental lineages have been classified. The 102 
spiral artery (SpA) TGCs line the maternal blood system on entry to the placenta, the canal 103 
(C-) TGCs line the maternal blood canals in the junctional zone and the channel (Ch-) 104 
TGCs line the maternal blood spaces located just beneath the decidua where maternal 105 
blood leaves the placenta [14, 23-25]. Placental lactogens are expressed by all TGC 106 
subtypes, the spongiotrophoblast and the glycogens cells. Moreover, the large nuclei of 107 
the TGCs result from endoreduplication with specific parts of their genome further over 108 
replicated including regions encoding placental lactogens [26]. Along with their close 109 
proximity to the maternal circulation, these gene amplification events suggest TGCs as a 110 
major source of placental lactogens in mice. In contrast, the human placenta appears to 111 
possess a single major cell type manufacturing hormones termed the syncytiotrophoblast. 112 
These multinucleated layer of cells is generated from the fusion of cytotrophoblast cells 113 
lying beneath, and both cell types overlie a core of mesenchynmal cells that make up the 114 
numerous chorionic villi of the human placenta [13]. 115 
 116 
The role of placental hormones in manipulating the mother to provide resources to her 117 
offspring both in utero and in the immediate postnatal period suggested placental 118 
hormones as candidates for the expression of parent-offspring conflict [27, 28]. Apart from 119 
one rare example in the new world mouse, Peromyscus [29], there is no evidence that 120 
placental hormones or their maternal receptors are directly subject to genomic imprinting. 121 
 6 
However, a fetally-derived product of the paternally-expressed imprinted delta-like 122 
homolog 1 gene (Dlk1) has recently been shown to reach the maternal circulation and 123 
influence maternal metabolism [30], and it is possible that the Igf2 gene product has a 124 
similar function [31]. We hypothesised an alternative mechanism whereby imprinting could 125 
influence placental hormone production - by regulating the placental lineages that express 126 
these hormones [32]. This hypothesis was based initially on our studies on one imprinted 127 
gene, Pleckstrin homology-like domain family a member 2 (Phlda2). Phlda2 is a maternally 128 
expressed imprinted gene that encodes a PH domain-only protein expressed most highly 129 
in the ectoplacental cone and the visceral endoderm of the yolk sac [33-35]. Our studies 130 
on Phlda2 revealed a precise function for this gene in negatively regulating the size of 131 
spongiotrophoblast compartment, without altering the gross contribution of other placental 132 
lineages [7, 36-39]. Loss-of-function of Phlda2 resulted in a much larger 133 
spongiotrophoblast, approximately twice the volume normally present. Conversely, a two-134 
fold gain in expression of Phlda2 (modeling loss-of-imprinting) reduced the size of this 135 
compartment by 50%. The spongiotrophoblast is a key site for the production of placental 136 
lactogens, pregnancy-specific glycoproteins and a number of other hormones important in 137 
pregnancy [14, 37]. Using the same dosage interogating approach applied to Phlda2, we 138 
have recently shown that overexpression of a second maternally expressed imprinted 139 
gene, Achaete-scute complex homolog 2 (Ascl2), repressed both the spongiotrophoblast 140 
and the parietal TGCs [40]. Although mouse models with increased dosage have not been 141 
reported, loss-of-function of studies suggest that Paternally expressed gene 3 (Peg3), 142 
Paternally expressed gene 10 (Peg10), Cyclin-dependent kinase inhibitor 1c (Cdkn1c) and 143 
several non-classically imprinted genes located on the X chromosome also regulate the 144 
placental endocrine lineages positively or negatively in a manner generally consistent with 145 
parental conflict [32]. As a consequence, imprinted genes indirectly modulate the 146 
expression of placental hormones by regulating the size of the placental endocrine 147 
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compartment. This is illustrated most elegantly with the Phlda2 gene where loss of 148 
expression resulted in a 2-fold increase in expression of the placental lactogens expressed 149 
in the spongiotrophoblast while a double dose of Phlda2 resulted in a 50% decrease in 150 
their expression [41]. 151 
 152 
Functional data demonstrating that imprinted genes regulate placental hormone lineages 153 
in species other than the mouse is sparse. Reduced expression of PHLDA2 is a common 154 
feature of bovine cloning associated with overgrowth of both the fetus and placenta but not 155 
the altered expression of placental hormones [42, 43]. Elevated placental PHLDA2 has 156 
been reported in a number of studies on human fetal growth restriction, fetal death and low 157 
birth weight [44]. In our recent study on women with a perception of reduced fetal 158 
movements (RFM), we found placental PHLDA2 expression was 2.3 fold higher in RFM 159 
pregnancies resulting in delivery of a growth restricted infant compared with a normal birth 160 
weight infant [45]. Importantly, we found a significant inverse association between 161 
placental PHLDA2 levels and maternal serum placental lactogen (hPL) levels suggesting 162 
that PHLDA2 may regulate the production of placental hormones in human pregnancies. 163 
In another study focusing on prenatal depression, we examined placental expression 164 
levels of four genes, PHLDA2, CDKN1C, PEG3 and PEG10, based on the conserved 165 
imprinting status between mouse and human and their predicted role in regulating 166 
production of placental hormones [32]. In women with clinically diagnosed depression 167 
during pregnancy, we observed significantly lower expression of placental PEG3. We also 168 
found low placental PEG3 in pregnancies where women reported a depressed mood 169 
assessed using two self-rating psychometric questionnaires: Edinburgh Postnatal 170 
Depression Scale (EPDS), used as a measure of maternal prenatal depressive symptoms 171 
[46] and the Spielberger State-Trait Anxiety Inventory (STAI), used as a measure of 172 
anxiety symptoms [47]. Both diagnosed and self-reported symptoms of depression were 173 
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also significantly associated with low expression of hPL Critically, we found a positive 174 
correlation between placental PEG3 and hPL expression. In mice, loss-of-function of Peg3 175 
has been reported to result in changes in the expression of a number of placental 176 
lactogens [48, 49] although a specific endocrine lineage analysis has not been performed. 177 
Together, these data are consistent with a role for PEG3 in regulating hPL expression in 178 
humans. Peg3 and another paternally expressed imprinted gene, Peg1, have previously 179 
been linked to maternal care in rodents [50, 51]. In both these reports the dam carried the 180 
inactivating mutation for the respective gene, with considerable impact on a number of 181 
physiological as well as neurological processes. Moreover, a recent study did not find a 182 
maternal care deficit when a second Peg3 targeted allele was generated, and examined 183 
on a different strain background [52]. A role for loss of Peg3 in the placenta influencing 184 
any aspect of maternal behaviour in rodents has yet to be reported. 185 
 186 
In human pregnancies, a number of complications can commonly co-occur. Women with 187 
prenatal depression are three times more likely to have a low birth weight baby [53]. 188 
Maternal depression in the first and second trimester is associated with an increased risk 189 
of gestational diabetes while women with gestation diabetes have a >4-fold risk of 190 
postnatal depression with elevated depressive symptoms particularly high among non-191 
obese women [54]. A recent systematic review reported that women with symptoms of 192 
postnatal depression were less likely to breastfeed exclusively and more likely to terminate 193 
breastfeeding earlier [55]. This could be interpreted to mean that postpartum depression 194 
negatively impacts maternal breast feeding behaviour or that pressures around breast 195 
feeding increase the risk of depression. However, given the potential for placental 196 
hormones to influence both lactation and maternal behaviour, it is possible that difficulties 197 
with breast feeding and postnatal depression are manifestations of the same underlying 198 
problem, placental endocrine dysfunction (Figure 1). Similarly, prenatal depression 199 
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accompanied by low birth weight could be indicative of placental endocrine dysfunction 200 
(Figure 1). As well as these manifestations of maladapted pregnancy, a transient increase 201 
in the risk of breast cancer diagnosis has been reported for first time mothers likely linked 202 
to the pregnancy induced changes in mammary development [56].  It is therefore possible 203 
that placental hormone dysfunction could influence both short term and long term risk of 204 
breast cancer. Measuring placental hormones in maternal blood is already an important 205 
diagnostic tool early in pregnancy and the use of DLK1 assays in characterising types of 206 
fetal growth restriction holds great promise [30]. New techniques such as multiplexed 207 
quantification of fetal RNAs circulating in maternal blood may provide even more accurate 208 
tools, and for a variety of conditions [57]. 209 
 210 
In summary, current data supports a conserved function in mammals for imprinted genes 211 
in regulating placental hormones via regulating the size of the placental endocrine 212 
compartment. These data essentially support the prediction by David Haig more than 20 213 
years ago that imprinted genes would regulate signaling between the mother and her 214 
fetus. Importantly for human pregnancies, placental hormones play key roles in driving the 215 
physiological and, potentially, behavioural adaptations required to support optimal fetal 216 
growth and postpartum care. It is therefore plausible that aberrant imprinting in the 217 
placenta contributes to the common co-occurrence of a number of complications of 218 
pregnancy including low birth weight, maternal mood disorders, gestational diabetes and 219 
poor breast feeding. Finally, given the link between all these complications and poor long 220 
term outcomes for children, the detrimental consequences of placental endocrine function 221 
may influence offspring wellbeing considerably beyond the period of pregnancy (Figure 1). 222 
 223 
  224 
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